Effects of enalapril and digoxin on left ventricular remodeling were e
valuated in a randomized placebo-controlled study on 68 patients with
chronic NYHA class II -- III heart failure due to dilated cardiomyopat
hy (n=33) and ischemic heart disease (n=35). All patients were in sinu
s rhythm. Patients were randomized for enalapril (group 1), digoxin (g
roup 2), or placebo (group 3). Duration of study was 3 months. Spirove
loergometry and cine magnetic resonance tomography were performed prio
r to and in the end of treatment. Dynamics of parameters of patient's
functional state in enalapril treated patients differed from that in p
atients receiving digoxin and placebo. In group I anaerobic threshold
and functional class improved by 6,1 and 10,7%, respectively (p<0,01)
while in other 2 groups the changes were either insignificant or negat
ive. Similar tendency was noted in results of magnetic resonance tomog
raphy. In enalapril group left ventricular volumes decreased while in
groups 2 and 3 increased. Ejection fraction rose in the enalapril grou
p, remained practically unchanged in digoxin treated patients, and dec
reased on placebo. Significant lowering of myocardial stress (by 30,9%
) and increase of relative wall thickness index (by 14,4%) occurred so
lely in the enalapril group while in other groups these parameters wor
sened. Thus comparison of results of 3- month treatment of patients wi
th chronic heart failure and sinus rhythm by enalapril, digoxin, or pl
acebo clearly indicated superiority of the angiotensin converting enzy
me inhibitor.